Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut Functions in C-Section Delivered Babies: A Pilot Study | Zendy

Labrini Baglatzi | Zendy; Stavroula Gavrili | Zendy; K. Stamouli | Zendy; S. Zachaki | Zendy; Laurent Favre | Zendy; Sophie Pecquet | Zendy; Jalil Benyacoub | Zendy; Christos Costalos | Zendy

Open Access

Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut Functions in C-Section Delivered Babies: A Pilot Study

Author(s) -

Labrini Baglatzi,

Stavroula Gavrili,

K. Stamouli,

S. Zachaki,

Laurent Favre,

Sophie Pecquet,

Jalil Benyacoub,

Christos Costalos

Publication year - 2016

Publication title -

clinical medicine insights pediatrics

Language(s) - English

Resource type - Journals

ISSN - 1179-5565

DOI - 10.4137/cmped.s33096

Subject(s) - probiotic , breast milk , bifidobacterium , immune system , starter , medicine , breast feeding , infant formula , randomized controlled trial , lactobacillus acidophilus , lactobacillus , biology , pediatrics , immunology , food science , bacteria , biochemistry , genetics , fermentation

In the absence of breast-feeding and its immunomodulatory factors, supplementation of starter infant formula (IF) with probiotics is currently used to support immune functions and gut development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research